Synthetic Biology Speeds Up Drug Target Discovery release_edqkyjcrnzagllefluhkk24isy

by Yixuan Xie, Yanfang Yang, Yu He, Xixi Wang, Peng Zhang, Haocheng Li, Shufang Liang

Published in Frontiers in Pharmacology by Frontiers Media SA.

2020   Volume 11, p119

Abstract

As a rising emerging field, synthetic biology intends to realize precise regulations of cellular network by constructing artificial synthetic circuits, and it brings great opportunities to treat diseases and discover novel drug targets. Depending on the combination mode of different logic gates, various synthetic circuits are created to carry out multilevel regulations. In given synthetic circuits, drugs often act as inputs to drive circuits operation. It is becoming available to construct drug-responsive gene circuits for experimentally treating various disease models, including metabolic disease, immunity disease, cancer and bacterial infection. Synthetic biology works well in association with the CRISPR system for drug target functional screening. Remarkably, more and more well-designed circuits are developed to discover novel drug targets and precisely regulate drug therapy for diseases.
In text/plain format

Archived Files and Locations

application/pdf  830.6 kB
file_ylz6tfeu6fbihlpwugxx52fyui
web.archive.org (webarchive)
fjfsdata01prod.blob.core.windows.net (publisher)

Web Captures

https://www.frontiersin.org/articles/10.3389/fphar.2020.00119/full
2020-02-28 12:17:30 | 39 resources
webcapture_piybdsuqfnarhheta2x57kuay4
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-02-26
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  1663-9812
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 5a5b1d5a-34e3-444f-ae08-6a0d144d124c
API URL: JSON